Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ytterbium(III) fluoride (YbF₃) is an inorganic compound used primarily as a radiopaque agent in dental and endodontic materials. It contains ytterbium—one of the lanthanide series elements—which has a high atomic number (Z=70), making YbF₃ highly opaque to X-rays and advantageous for enhancing the visibility of dental restorations and cements in radiographic imaging[1][2][3][4][5][6]. YbF₃ is not a biological receptor, enzyme, or pharmacological target, but rather a filler added to dental materials to achieve sufficient radiopacity without markedly altering other key physical or bioactive properties when used at appropriate concentrations (typically 2.5–30% by weight). It is not implicated in physiological signaling or disease pathways. Increasing concentrations may affect some mechanical properties such as compressive strength and final setting time, but YbF₃ is considered safe and effective for its intended material science application at recommended levels[2][3][6]. It does not interact with drugs and is not a therapeutic or diagnostic target in the conventional biochemical sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ytterbium(III) fluoride (YbF₃).